| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity
|
Boonyasuppayakorn, Siwaporn
|
|
2014
|
106 |
C |
p. 125-134
10 p.
|
article
|
| 2 |
A novel neutralizing antibody against diverse clades of H5N1 influenza virus and its mutants capable of airborne transmission
|
Wu, Ruiping
|
|
2014
|
106 |
C |
p. 13-23
11 p.
|
article
|
| 3 |
Anti-inflammatory and antiviral effects of indirubin derivatives in influenza A (H5N1) virus infected primary human peripheral blood-derived macrophages and alveolar epithelial cells
|
Mok, Chris K.P.
|
|
2014
|
106 |
C |
p. 95-104
10 p.
|
article
|
| 4 |
Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery
|
Coutard, Bruno
|
|
2014
|
106 |
C |
p. 61-70
10 p.
|
article
|
| 5 |
Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening
|
Lo, Michael K.
|
|
2014
|
106 |
C |
p. 53-60
8 p.
|
article
|
| 6 |
High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses
|
Uebelhoer, Luke S.
|
|
2014
|
106 |
C |
p. 86-94
9 p.
|
article
|
| 7 |
Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms
|
Boglione, Lucio
|
|
2014
|
106 |
C |
p. 105-110
6 p.
|
article
|
| 8 |
Inhibition of hepatitis C virus infection by NS5A-specific aptamer
|
Yu, Xiaoyan
|
|
2014
|
106 |
C |
p. 116-124
9 p.
|
article
|
| 9 |
Inside Back Cover: Notes to Authors
|
|
|
2014
|
106 |
C |
p. IBC-
1 p.
|
article
|
| 10 |
Molecular basis of the association of H208Y and thymidine analogue resistance mutations M41L, L210W and T215Y in the HIV-1 reverse transcriptase of treated patients
|
Betancor, Gilberto
|
|
2014
|
106 |
C |
p. 42-52
11 p.
|
article
|
| 11 |
One Health approach to Rift Valley fever vaccine development
|
Kortekaas, Jeroen
|
|
2014
|
106 |
C |
p. 24-32
9 p.
|
article
|
| 12 |
Prelim II: Editorial Board
|
|
|
2014
|
106 |
C |
p. ii-
1 p.
|
article
|
| 13 |
Probing the molecular mechanism of action of the HIV-1 reverse transcriptase inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) using pre-steady-state kinetics
|
Muftuoglu, Yagmur
|
|
2014
|
106 |
C |
p. 1-4
4 p.
|
article
|
| 14 |
Structure-based predictors of resistance to the HIV-1 integrase inhibitor Elvitegravir
|
Masso, Majid
|
|
2014
|
106 |
C |
p. 5-12
8 p.
|
article
|
| 15 |
Substituted 2,6-bis(benzimidazol-2-yl)pyridines: A novel chemical class of pestivirus inhibitors that targets a hot spot for inhibition of pestivirus replication in the RNA-dependent RNA polymerase
|
Musiu, Simone
|
|
2014
|
106 |
C |
p. 71-79
9 p.
|
article
|
| 16 |
The multi-targeted kinase inhibitor sorafenib inhibits enterovirus 71 replication by regulating IRES-dependent translation of viral proteins
|
Gao, Meng
|
|
2014
|
106 |
C |
p. 80-85
6 p.
|
article
|
| 17 |
Triggering unfolded protein response by 2-Deoxy-d-glucose inhibits porcine epidemic diarrhea virus propagation
|
Wang, Yue
|
|
2014
|
106 |
C |
p. 33-41
9 p.
|
article
|
| 18 |
Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle
|
Blanchet, Matthieu
|
|
2014
|
106 |
C |
p. 111-115
5 p.
|
article
|
Journal description